Safety and effectiveness of dulaglutide in Chinese adults with type 2 diabetes mellitus in a real-world setting: A prospective, observational post-marketing study.

Li-Xin GuoLi LiQiurong YuNa WangJun ChenYue XiHuan WangYihua WangJiawei Xu

Published in: Diabetes, obesity & metabolism (2023)

Dulaglutide showed a safety profile consistent with previous reports and significantly reduced HbA1c in a real-world setting. These findings support the clinical use of dulaglutide and inform the individualized treatment of patients with T2DM in China.

Keyphrases

randomized controlled trial
systematic review
type diabetes
emergency department
adipose tissue
replacement therapy